Investment Summary |
|
|---|---|
| Date | 2025-05-14 |
| Target | NorthX Biologics |
| Sector | Life Science |
| Investor(s) | Signet Healthcare Partners |
| Deal Type | Growth Capital |
| Advisor(s) | Setterwalls Advokatbyrå AB (Legal) |
SEARCH BY
| Category | Growth Capital Firm |
|---|---|
| Founded | 1998 |
| PE ASSETS | 600M USD |
| Size | Middle-Market |
| Type | Sector Focused |
Signet Healthcare Partners is a growth capital firm focused on the healthcare sector. Specific areas of interest include specialty pharmaceuticals, pharmaceutical services, medical devices, and diagnostics. Signet will consider opportunities throughout North America and Europe and looks to commit $10 to $50 million per transaction. Signet Healthcare Partners was established in 1998 and is headquartered in New York, New York.
| DEAL STATS | # |
|---|---|
| Overall | 16 of 16 |
| Sector: Life Science M&A | 13 of 13 |
| Type: Growth Capital M&A Deals | 11 of 11 |
| Country: Sweden M&A | 1 of 1 |
| Year: 2025 M&A | 1 of 1 |
| DATE | TARGET | DEAL TYPE | VALUE |
|---|---|---|---|
| 2025-02-04 |
Pharmaceutics International
Hunt Valley, Maryland, United States Pharmaceutics International (Pii) is a privately held contract development and manufacturing organization providing dosage form development and manufacturing services to the global pharmaceutical industry. It provides preformulation testing, formulation development, clinical and commercial CGMP manufacturing of solid, parenteral, inhalation, semi-solid and liquid dosage forms, clinical packaging and labeling, and analytical services. Pharmaceutics International was founded in 1994 and is based in Hunt Valley, Maryland. |
Sell | - |
